[go: up one dir, main page]

WO2001079974A3 - Haplotypes of the f9 gene - Google Patents

Haplotypes of the f9 gene Download PDF

Info

Publication number
WO2001079974A3
WO2001079974A3 PCT/US2001/012012 US0112012W WO0179974A3 WO 2001079974 A3 WO2001079974 A3 WO 2001079974A3 US 0112012 W US0112012 W US 0112012W WO 0179974 A3 WO0179974 A3 WO 0179974A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
haplotypes
disclosed
polymorphisms
haplotyping
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/012012
Other languages
French (fr)
Other versions
WO2001079974A2 (en
Inventor
Anne Chew
Julie Y Choi
Beena Koshy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Priority to AU2001253431A priority Critical patent/AU2001253431A1/en
Publication of WO2001079974A2 publication Critical patent/WO2001079974A2/en
Publication of WO2001079974A3 publication Critical patent/WO2001079974A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Novel single nucleotide polymorphisms in the human Coagulation factor IX (F9) gene are described. In addition, various genotypes, haplotypes and haplotype pairs for the F9 gene that exist in the population are described. Compositions and methods for haplotyping and/or genotyping the F9 gene in an individual are also disclosed. Polynucleotides containing one or more of the F9 polymorphisms disclosed herein are also described.
PCT/US2001/012012 2000-04-12 2001-04-11 Haplotypes of the f9 gene Ceased WO2001079974A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001253431A AU2001253431A1 (en) 2000-04-12 2001-04-11 Haplotypes of the f9 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19641900P 2000-04-12 2000-04-12
US60/196,419 2000-04-12

Publications (2)

Publication Number Publication Date
WO2001079974A2 WO2001079974A2 (en) 2001-10-25
WO2001079974A3 true WO2001079974A3 (en) 2002-03-21

Family

ID=22725336

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/012012 Ceased WO2001079974A2 (en) 2000-04-12 2001-04-11 Haplotypes of the f9 gene

Country Status (2)

Country Link
AU (1) AU2001253431A1 (en)
WO (1) WO2001079974A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104046699B (en) * 2014-07-08 2016-03-02 上海交通大学医学院附属瑞金医院 F9 gene copy number variation detection kit

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 23 November 1999 (1999-11-23), XP002906035, Database accession no. AL033403 *
DATABASE SNP [online] NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION, NATIONAL LIBRARY OF MEDICINE, NIH (BETHESDA, MD, USA); January 2001 (2001-01-01), XP002906034, retrieved from ss7662 accession no. NCBI Database accession no. rs6048 *
YOSHITAKE S. ET AL.: "Nucleotide sequence of the gene for human factor IX", BIOCHEMISTRY, vol. 24, 1985, pages 3736 - 3750, XP002906033 *

Also Published As

Publication number Publication date
AU2001253431A1 (en) 2001-10-30
WO2001079974A2 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
WO2001079234A3 (en) Haplotypes of the apoe gene
WO2001079229A3 (en) Haplotypes of the cxcr4 gene
WO2001090123A3 (en) Haplotypes of the agtrl1 gene
WO2001079230A3 (en) Haplotypes of the ugt1a1 gene
WO2001079228A3 (en) Haplotypes of the f12 gene
WO2001077124A3 (en) Haplotypes of the apoa4 gene
WO2001079974A3 (en) Haplotypes of the f9 gene
WO2001077363A3 (en) Haplotypes of the impdh2 gene
WO2001079224A3 (en) Haplotypes of the cyp8b1 gene
WO2002018414A3 (en) Haplotypes of the bf gene
WO2001077131A3 (en) Haplotypes of the bglap gene
WO2001079240A3 (en) Haplotypes of the rangap1 gene
WO2001079218A3 (en) Haplotypes of the calm1 gene
WO2001079219A3 (en) Haplotypes of the ache gene
WO2001077129A3 (en) Haplotypes of the apoc1 gene
WO2001079232A3 (en) Haplotypes of the mpl gene
WO2001072965A3 (en) Haplotypes of the fkbp8 gene
WO2001072966A3 (en) Haplotypes of the pltp gene
WO2001079223A3 (en) Haplotypes of the akr1b1 gene
WO2001090127A3 (en) Haplotypes of the hoxd3 gene
WO2001077127A3 (en) Haplotypes of the apoc4 gene
WO2001077132A3 (en) Haplotypes of the il5 gene
WO2001079237A3 (en) Haplotypes of the galr1 gene
WO2001075065A3 (en) Haplotypes of the gp1ba gene
WO2001077130A3 (en) Haplotypes of the apoa2 gene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP